ESC 365 - Predictors and Outcomes of Atrial Fibrillation Progression in Patients with Device-Detected Subclinical AF: Insights from the ARTESiA Trial

ESC Premium Access

Predictors and Outcomes of Atrial Fibrillation Progression in Patients with Device-Detected Subclinical AF: Insights from the ARTESiA Trial

Session: Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment

Topic: Defining Types of Atrial Fibrillation

Speaker: Professor G. Boriani (Modena, IT)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)

53 presentations

5 followers

4 more presentations in this session

Catheter ablation in persistent atrial fibrillation: long term outcomes of the CAPLA multicentre randomised trial of pulmonary vein isolation(PVI) vs PVI plus posterior left atrial wall isolation(PWI)

Speaker: Doctor P. Kistler (Melbourne, AU)

Randomized evaluation of decision support interventions for atrial fibrillation: Anticoagulant adherence after shared decision making interventions for stroke prevention in atrial fibrillation

Speaker: Professor E. Jackson (Birmingham, US)

Biomolecule-based prediction of sinus rhythm and interaction with early rhythm control: EAST-AFNET 4 biomolecule study

Speaker: Professor L. Fabritz (Hamburg, DE)

The Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation Extend

Speaker: Doctor A. Tang (London, CA)

Access the full session

Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment

Speakers: Professor G. Boriani, Doctor P. Kistler, Professor E. Jackson, Professor L. Fabritz, Doctor A. Tang

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources